tagged standing ovations
Presented at #ASCO26: Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results:
— @NEJM
contributed by Andy on Jun 9, 2026 in curves, things that go down, standing ovations
end of the notebook.